$ACRS Cashflow Statement | Understand Stock

$ACRS

$3.79 +$0.04 (1.07%) Close

$ACRS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation expense
Revaluation of contingent consideration
Loss on extinguishment of debt
In-process research and development expense
Intangible asset impairment charge
Deferred taxes
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other assets
Accounts receivable, prepaid expenses and other assets
Accounts payable
Accrued expenses
Accrued expenses and other liabilities
Deferred income

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Purchases of marketable securities
Proceeds from sales and maturities of marketable securities
Payments of deferred transaction consideration for in-licensed assets
Acquisition of in-licensed assets, including transaction costs
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock in connection with public offerings, net of issuance costs
Proceeds from issuance of common stock under securities purchase agreement, net of issuance costs
Public Offering
At The Market Offering
Total proceeds from issuance of common stock under securities purchase agreement, net of issuance costs

Repayment of debt
Payments of deferred transaction consideration for in-licensed assets
Payments of employee withholding taxes related to restricted stock unit award vesting
Proceeds from exercise of employee stock options and the issuance of stock
Net cash (used in) provided by financing activities

Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of non-cash investing and financing activities:
Additions to property and equipment included in accounts payable
Fair value of warrants issued in connection with in-license agreement
Deferred transaction consideration in connection with in-license agreement

Comments